Literature DB >> 1833760

Immunoregulatory activity of the T-cell receptor alpha chain demonstrated by retroviral gene transfer.

D R Green1, R Bissonnette, H G Zheng, T Onda, F Echeverri, R J Mogil, J K Steele, M Voralia, A Fotedar.   

Abstract

We have previously described an antigen-specific I-Ad-restricted T-cell hybridoma, A1.1, that constitutively releases an antigen-specific immunoregulatory activity into supernatants. Using retrovirally mediated gene transfer, we have found that transfer of the T-cell receptor alpha chain (TCR alpha) gene from A1.1 to a number of other T-cell hybridomas effectively transferred the ability to produce the activity. Gene transfer of the TCR beta chain (TCR beta), however, did not transfer this ability. The regulatory activity from cells expressing the A1.1 TCR alpha bound to and was eluted from an anti-TCR alpha monoclonal antibody and displayed fine antigenic specificity identical to that of supernatants from A1.1. The possibility that this activity represents a secreted form of the TCR alpha (as opposed to shed cell-surface TCR) was examined in BW1100 cells, lacking TCR alpha and TCR beta, which produced the antigen-specific activity after gene transfer of the A1.1 TCR alpha gene. The expression of the immunoregulatory activity in supernatants correlated with a direct antigen-binding activity as detected by ELISA, thus raising the possibility that antigen binding is relevant to the mechanism of action of the soluble TCR alpha. We discuss these observations and our earlier studies suggesting an immunoregulatory role for soluble TCR alpha.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833760      PMCID: PMC52531          DOI: 10.1073/pnas.88.19.8475

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Serologic, biologic, and western blot analysis of a T suppressor factor with specificity for the hapten 4-hydroxy-3-nitrophenyl acetyl derived from serum-free medium.

Authors:  M J Gallina; V K Kuchroo; J K Steele
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

2.  Antigen/major histocompatibility complex-specific activation of murine T cells transfected with functionally rearranged T-cell receptor genes.

Authors:  C L Kuo; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides.

Authors:  M D Howell; S T Winters; T Olee; H C Powell; D J Carlo; S W Brostoff
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

4.  Cloned suppressor T cells derived from mice tolerized with conjugates of antigen and monomethoxypolyethylene glycol. Relationship between monoclonal T suppressor factor and the T cell receptor.

Authors:  M Takata; P K Maiti; R T Kubo; Y H Chen; V Holford-Strevens; E S Rector; A H Sehon
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

5.  Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.

Authors:  A A Vandenbark; G Hashim; H Offner
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

6.  Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.

Authors:  O Lider; T Reshef; E Beraud; A Ben-Nun; I R Cohen
Journal:  Science       Date:  1988-01-08       Impact factor: 47.728

7.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  Sequence and expression of transcripts of the T-cell antigen receptor alpha-chain gene in a functional, antigen-specific suppressor-T-cell hybridoma.

Authors:  K Imai; M Kanno; H Kimoto; K Shigemoto; S Yamamoto; M Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

Authors:  D Sun; Y Qin; J Chluba; J T Epplen; H Wekerle
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

10.  Predominant use of a V alpha gene segment in mouse T-cell receptors for cytochrome c.

Authors:  A Winoto; J L Urban; N C Lan; J Goverman; L Hood; D Hansburg
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

View more
  8 in total

Review 1.  Antigen-specific suppressor factor: missing pieces in the puzzle.

Authors:  R M O'Hara
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

2.  CD27-CD70 interactions regulate B-cell activation by T cells.

Authors:  T Kobata; S Jacquot; S Kozlowski; K Agematsu; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

3.  Immunoregulatory activity of a T-cell receptor alpha chain demonstrated by in vitro transcription and translation.

Authors:  T Onda; T Brunner; H Messier; R Bissonnette; F Echeverri; G Baier; A Fotedar; D R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 4.  Therapeutic advances in immunosuppression.

Authors:  A W Thomson; J V Forrester
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

5.  Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor.

Authors:  C M Meyers; C J Kelly
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Molecular cloning and characterization of a cDNA encoding monoclonal nonspecific suppressor factor.

Authors:  M Nakamura; R M Xavier; T Tsunematsu; Y Tanigawa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

7.  TCR-alpha chain-like molecule is involved in the mechanism of antigen-non-specific suppression of a ubiquitin-like protein.

Authors:  M Nakamura; T Tsunematsu; Y Tanigawa
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

8.  Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.

Authors:  H Gomi; Y Tagaya; T Nakano; T Mikayama; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.